These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
660 related articles for article (PubMed ID: 8558641)
1. Intravesical versus intravesical plus intradermal bacillus Calmette-Guerin: a prospective randomized study in patients with recurrent superficial bladder tumors. Lüftenegger W; Ackermann DK; Futterlieb A; Kraft R; Minder CE; Nadelhaft P; Studer UE J Urol; 1996 Feb; 155(2):483-7. PubMed ID: 8558641 [TBL] [Abstract][Full Text] [Related]
2. Weekly mitomycin C followed by monthly bacillus Calmette-Guerin or alternating monthly interferon-alpha2B and bacillus Calmette-Guerin for prophylaxis of recurrent papillary superficial bladder carcinoma. Kaasinen E; Rintala E; Pere AK; Kallio J; Puolakka VM; Liukkonen T; Tuhkanen K J Urol; 2000 Jul; 164(1):47-52. PubMed ID: 10840422 [TBL] [Abstract][Full Text] [Related]
3. A randomized prospective study comparing long-term intravesical instillations of mitomycin C and bacillus Calmette-Guerin in patients with superficial bladder carcinoma. Lundholm C; Norlén BJ; Ekman P; Jahnson S; Lagerkvist M; Lindeborg T; Olsson JL; Tveter K; Wijkstrom H; Westberg R; Malmström PU J Urol; 1996 Aug; 156(2 Pt 1):372-6. PubMed ID: 8683682 [TBL] [Abstract][Full Text] [Related]
4. Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer. Shepherd AR; Shepherd E; Brook NR Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012112. PubMed ID: 28268259 [TBL] [Abstract][Full Text] [Related]
5. A randomized multicenter trial of adjuvant therapy in superficial bladder cancer: transurethral resection only versus transurethral resection plus mitomycin C versus transurethral resection plus bacillus Calmette-Guerin. Participating Clinics. Krege S; Giani G; Meyer R; Otto T; Rübben H J Urol; 1996 Sep; 156(3):962-6. PubMed ID: 8709374 [TBL] [Abstract][Full Text] [Related]
6. [Intravesical instillation of bacillus Calmette-Guerin for superficial bladder carcinoma: study on significance of additional maintenance instillations of bacillus Calmette-Guerin]. Yabusaki N; Komatsu H; Tago K; Yamada Y; Ueno A Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):290-6. PubMed ID: 1904120 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of intravesical bacillus Calmette-Guérin therapy with maintenance for urinary bladder carcinoma in situ: About 47 cases. Sallami S; Khouni H; Ben Atta M; Abou El Makarim S; Zouari MB; Ben Rhouma S Tunis Med; 2016 Dec; 94(12):844. PubMed ID: 28994883 [TBL] [Abstract][Full Text] [Related]
8. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer]. Yi SH; Ye G; Wang XW; Jin HS; Zhang YN; Yan ZL Ai Zheng; 2008 Nov; 27(11):1208-11. PubMed ID: 19000455 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological evaluation of repeated courses of intravesical bacillus Calmette-Guerin instillation for preventing recurrence of initially resistant superficial bladder cancer. Okamura T; Tozawa K; Yamada Y; Sakagami H; Ueda K; Kohri K J Urol; 1996 Sep; 156(3):967-71. PubMed ID: 8709375 [TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: prospective randomised FinnBladder-4 study. Järvinen R; Marttila T; Kaasinen E; Rintala E; Aaltomaa S; Kallio J; Liukkonen T; Puolakka VM; Seppänen M; Tuhkanen K; Vaarala M; Viitanen J; Boström PJ; Eur Urol; 2015 Oct; 68(4):611-7. PubMed ID: 25748117 [TBL] [Abstract][Full Text] [Related]
11. Sufficient prophylactic efficacy with minor adverse effects by intravesical instillation of low-dose bacillus Calmette-Guérin for superficial bladder cancer recurrence. Irie A; Uchida T; Yamashita H; Matsumoto K; Satoh T; Koh H; Shimura S; Iwamura M; Baba S Int J Urol; 2003 Apr; 10(4):183-9. PubMed ID: 12657096 [TBL] [Abstract][Full Text] [Related]
13. Use of maintenance intravesical bacillus Calmette-Guérin (BCG), with or without intradermal BCG, in patients with recurrent superficial bladder cancer. Long-term follow-up of a randomized phase 2 study. Witjes JA; Fransen MP; van der Meijden AP; Doesburg WH; Debruyne FM Urol Int; 1993; 51(2):67-72. PubMed ID: 8351757 [TBL] [Abstract][Full Text] [Related]
14. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer. Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510 [TBL] [Abstract][Full Text] [Related]
15. The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: a pilot study. Pan CW; Shen ZJ; Ding GQ J Urol; 2008 Apr; 179(4):1307-11; discussion 1311-2. PubMed ID: 18289576 [TBL] [Abstract][Full Text] [Related]
16. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations. Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315 [TBL] [Abstract][Full Text] [Related]
17. Intravesical immunoprophylaxis in recurrent superficial bladder cancer (Stage T1): multicenter trial comparing bacille Calmette-Guérin and interferon-alpha. Jimenez-Cruz JF; Vera-Donoso CD; Leiva O; Pamplona M; Rioja-Sanz LA; Martinez-Lasierra M; Flores N; Unda M Urology; 1997 Oct; 50(4):529-35. PubMed ID: 9338727 [TBL] [Abstract][Full Text] [Related]
18. Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-α2a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma: FinnBladder-6 Study. Marttila T; Järvinen R; Liukkonen T; Rintala E; Boström P; Seppänen M; Tammela T; Hellström P; Aaltomaa S; Leskinen M; Raitanen M; Kaasinen E; Eur Urol; 2016 Aug; 70(2):341-7. PubMed ID: 27085624 [TBL] [Abstract][Full Text] [Related]
19. Do bacteriostatic urethral lubricants affect the clinical efficacy of intravesical bacillus Calmette-Guérin therapy? Loertzer H; Brake M; Horsch R; Keller H Urology; 2001 May; 57(5):900-5. PubMed ID: 11337290 [TBL] [Abstract][Full Text] [Related]
20. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence]. Ding GQ; Shen ZJ; Lu J; Jin XD; Chen J; Shi SF Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1457-60. PubMed ID: 16318813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]